GLP-1 is an incretin, which stimulates insulin secretion from pancreatic β-cell in a glucose-dependent fashion (Doyle and Egan, 2007), and increasing and stabilizing GLP-1 levels is an important strategy to manage type 2 diabetes (Nauck et al., 2011). This evidence concerns the gene INS and type 2 diabetes mellitus.